Patients with chronic or acute liver failure frequently show profound abnormalities in their hemostatic system. Whereas routine laboratory tests of hemostasis suggest these hemostatic alterations result in a bleeding diathesis, accumulating evidence from both clinical and laboratory studies suggest that the situation is more complex. The average patient with liver failure may be in hemostatic balance despite prolonged routine coagulation tests, since both pro- and antihemostatic factors are affected, the latter of which are not well reflected in routine coagulation testing. However, this balance may easily tip towards a hypo- or hypercoagulable situation. Indeed, patients with liver disease may encounter both hemostasis-related bleeding episodes as well as thrombotic events. During the 3rd International Symposium on Coagulopathy and Liver disease, held in Groningen, The Netherlands (18-19 September 2009), a multidisciplinary panel of experts critically reviewed the current data concerning pathophysiology and clinical consequences of hemostatic disorders in patients with liver disease. Highlights of this symposium are summarized in this review.

Hemostasis and thrombosis in patients with liver disease : the ups and downs / T. Lisman, S. H. Caldwell, A. K. Burroughs, P. G. Northup, M. Senzolo, R. T. Stravitz, A. Tripodi, J. F. Trotter, D. C. Valla, R. J. Porte. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - 53:2(2010 Aug), pp. 362-371. [10.1016/j.jhep.2010.01.042]

Hemostasis and thrombosis in patients with liver disease : the ups and downs

A. Tripodi;
2010

Abstract

Patients with chronic or acute liver failure frequently show profound abnormalities in their hemostatic system. Whereas routine laboratory tests of hemostasis suggest these hemostatic alterations result in a bleeding diathesis, accumulating evidence from both clinical and laboratory studies suggest that the situation is more complex. The average patient with liver failure may be in hemostatic balance despite prolonged routine coagulation tests, since both pro- and antihemostatic factors are affected, the latter of which are not well reflected in routine coagulation testing. However, this balance may easily tip towards a hypo- or hypercoagulable situation. Indeed, patients with liver disease may encounter both hemostasis-related bleeding episodes as well as thrombotic events. During the 3rd International Symposium on Coagulopathy and Liver disease, held in Groningen, The Netherlands (18-19 September 2009), a multidisciplinary panel of experts critically reviewed the current data concerning pathophysiology and clinical consequences of hemostatic disorders in patients with liver disease. Highlights of this symposium are summarized in this review.
Bleeding; Hemostasis; Liver disease; Non-alcoholic steatohepatitis; Platelet; Thrombin; Thrombosis
Settore BIO/12 - Biochimica Clinica e Biologia Molecolare Clinica
ago-2010
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/153836
Citazioni
  • ???jsp.display-item.citation.pmc??? 68
  • Scopus 284
  • ???jsp.display-item.citation.isi??? 230
social impact